Remon Medical ploughs $16m into intra-body communication technology
This article was originally published in Clinica
Executive Summary
Israeli firm Remon Medical Technologies is pressing on with the development of products based on its miniaturised intra-body communication technology, using $16m raised from a Series C financing.